AU2013245463B2 - Immunoglobulin Chimeric Monomer-Dimer Hybrids - Google Patents
Immunoglobulin Chimeric Monomer-Dimer HybridsInfo
- Publication number
- AU2013245463B2 AU2013245463B2 AU2013245463A AU2013245463A AU2013245463B2 AU 2013245463 B2 AU2013245463 B2 AU 2013245463B2 AU 2013245463 A AU2013245463 A AU 2013245463A AU 2013245463 A AU2013245463 A AU 2013245463A AU 2013245463 B2 AU2013245463 B2 AU 2013245463B2
- Authority
- AU
- Australia
- Prior art keywords
- chimeric monomer
- dimer hybrids
- immunoglobulin chimeric
- polypeptide chain
- monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000539 dimer Substances 0.000 title abstract 3
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 abstract 2
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 abstract 2
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a chimeric monomer-dimer hybrid protein wherein said protein comprises a first and a second polypeptide chain, said first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and said second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013245463A AU2013245463B2 (en) | 2003-05-06 | 2013-10-15 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| AU2016244273A AU2016244273B2 (en) | 2003-05-06 | 2016-10-13 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| AU2019200306A AU2019200306B2 (en) | 2003-05-06 | 2019-01-16 | Immunoglobulin chimeric monomer-dimer hybrids |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/469,600 | 2003-05-06 | ||
| US60/487,964 | 2003-07-17 | ||
| US60/539,207 | 2004-01-26 | ||
| AU2013204787A AU2013204787B2 (en) | 2003-05-06 | 2013-04-12 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| AU2013245463A AU2013245463B2 (en) | 2003-05-06 | 2013-10-15 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013204787A Division AU2013204787B2 (en) | 2003-05-06 | 2013-04-12 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016244273A Division AU2016244273B2 (en) | 2003-05-06 | 2016-10-13 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013245463A1 AU2013245463A1 (en) | 2013-10-31 |
| AU2013245463B2 true AU2013245463B2 (en) | 2016-07-14 |
Family
ID=49485875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013245463A Expired AU2013245463B2 (en) | 2003-05-06 | 2013-10-15 | Immunoglobulin Chimeric Monomer-Dimer Hybrids |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2013245463B2 (en) |
-
2013
- 2013-10-15 AU AU2013245463A patent/AU2013245463B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013245463A1 (en) | 2013-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1600011I1 (en) | Immunoglobulin chimeric monomer-dimer hybrids | |
| WO2003011115A3 (en) | Peptide-based multimeric targeted contrast agents | |
| EP1553975B8 (en) | Optimized fc variants and methods for their generation | |
| WO2003020756A3 (en) | Hybrid and tandem expression of neisserial proteins | |
| IL157446A0 (en) | Increased recovery of active proteins | |
| WO2004113493A3 (en) | Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site | |
| WO2003011878A3 (en) | Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity | |
| IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
| AU2002345804A1 (en) | Antimicrobially active peptide | |
| AU2013245463B2 (en) | Immunoglobulin Chimeric Monomer-Dimer Hybrids | |
| WO2002074916A9 (en) | Reg-like protein immunoglobulin derived proteins, compositions, methods and uses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| HB | Alteration of name in register |
Owner name: BIOVERATIV THERAPEUTICS INC. Free format text: FORMER NAME(S): BIOGEN HEMOPHILIA INC. |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |